All patients with HF were treated according to current HF management guidelines, including diuretics, βblocker, Aldosterone receptor antagonist, Angiotensin converting enzyme inhibitor/Angiotensin receptor antagonist/Angiotensin receptor neprilysin inhibitor, and Sodium-glucose cotransporter 2 inhibitor. This evidence concerns the gene SLC5A2 and hydrops fetalis.